Overview:
On January 7th, 2020, NMPA published a new guideline on “Real-World Evidence that defines Real-World Data (RWD) and Real-World Evidence (RWE) terms and clarifies their use during drugs’ research and development and registration in China.
Download our Whitepaper for a summary of the important implications introduced by this new guideline.
ABOUT GLOBAL REGULATORY PARTNERS INC.
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and Argentina. GRP helps many life science companies register their products in different countries in compliance with local regulations.